• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BCA
Click for more information
0.00% 10.0¢

BLACK CANYON LIMITED

Market Cap $7.014M  ! watchlist Created with Sketch. Add to my watchlist
Metals & Mining Industrial Metals & Minerals

Black Canyon Limited is an Australia-based company, which is engaged in manganese... Black Canyon Limited is an Australia-based company, which is engaged in manganese exploration and development in Western Australia's Pilbara region. The Company's projects include Balfour Manganese Field, Braeside, Oakover West and Oakover East. The Balfour Manganese Field projects include Flanagan Bore, KR1 and KR2 Deposits, and Balfour East and Damsite Deposits. It has consolidated a significant land holding totaling 2,400 square kilometers (km2) in the underexplored Balfour Manganese Field and across the Oakover Basin, in Western Australia. The Company has around 75% interest in the Carawine JV Project tenements covering approximately 457 km2 of tenure located south and west of the operating Woodie-Woodie manganese mine. The Company has a portfolio of tenements that are prospective for manganese mineralization, such as Woodie-Woodie hydrothermal (high-grade manganese) and Supergene Balfour style manganese deposits (medium-grade manganese/ iron). It owns 100% of the Wandanya project.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
BCA
Ann: Quarterly Activities and Cashflow Report 		23/04/24 2 408
23/04/24 Last post  Quay Street Comments Created with Sketch.  2  Views Created with Sketch.  408 
BCA
Ann: Metallurgical testwork delivers 35% plus Mn concentrate 		27/03/24 3 998
27/03/24 Last post  Quay Street Comments Created with Sketch.  3  Views Created with Sketch.  998 
BCA
Ann: Quarterly Activity and Cashflow Report 		14/03/24 3 1.2K
14/03/24 Last post  Quay Street Comments Created with Sketch.  3  Views Created with Sketch.  1.2K 
BCA
Ann: Half Year Accounts 		14/03/24 0 152
14/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  152 
BCA
Ann: Corporate Presentation RIU Conference 		13/02/24 0 327
13/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  327 
BCA
Ann: Updated Mineral Resource Estimate Presentation 		16/01/24 14 3.8K
16/01/24 Last post  tepidcopper Comments Created with Sketch.  14  Views Created with Sketch.  3.8K 
BCA
Ann: Exploration Targets Estimated across the Balfour Mn Field 		16/01/24 0 304
16/01/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  304 
BCA
Ann: Cleansing Notice 		22/12/23 0 121
22/12/23 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  121 

See All Discussions arrow Created with Sketch.

Timeline

Quarterly Activities and Cashflow Report
23 Apr 08:24
 
Metallurgical testwork delivers 35% plus Mn concentrate
26 Mar 08:54
 
Half Year Accounts
14 Mar 09:12
 
Corporate Presentation RIU Conference
13 Feb 08:23
 
Quarterly Activity and Cashflow Report
30 Jan 08:17
 
Exploration Targets Estimated across the Balfour Mn Field
16 Jan 08:20
 
View More arrow Created with Sketch.

Featured News

NCK Nick Scali moves into the UK market through Fabb Furniture acquisition
right-arrow Created with Sketch.
CC9 Chariot ends quarter charged up on lithium find in Wyoming
right-arrow Created with Sketch.
BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.
ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.

(20min delay)
Last
10.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $7.014M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 10000 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
12.0¢ 69658 1
View Market Depth
Last trade - 16.12pm 26/04/2024 (20 minute delay) ?
BCA (ASX) Chart

Top Stories

Raiden’s jump into lithium territory in WA’s Pilbara echoes earlier journey by Azure

In its bid to define a noteworthy lithium deposit in WA’s Pilbara region, Raiden Resources is following in the footsteps of another explorer.
Regal copper grades at Gascoyne play see shares jump 33% for Augustus Augustus Minerals is reporting high grade copper rock chip results at Ti-Tree in WA based on recent fieldwork.
Recce Pharmaceuticals up 6% on new antibiotic production milestone Recce Pharmaceuticals (ASX:RCE) is trading up more than 6 per cent after producing a 5000-dose batch of its new antibiotic RECCE 327 (R327) under Good Manufacturing Practises (GMP) standards.
Week 17 Wrap: BHP-Anglo deal helps push down ASX; US data of concern but AI bulls happy The big thematics and headlines that drove the ASX this week, plus, the headlines I think investors ought to be keeping eyes on.
Are there gains to be made with the grocery giants? There is a growing storm of controversy around Coles (ASX:COL) and Woolworths (ASX:WOW) as they face intense scrutiny over price hikes and supplier pressures in a Senate inquiry. This raises an interesting question as to whether investors should cut ties with these corporate giants or wheth...

Featured News

BHP BHP confirms £31.1B takeover bid for Anglo American
right-arrow Created with Sketch.
CC9 Chariot ends quarter charged up on lithium find in Wyoming
right-arrow Created with Sketch.
NEWS Recharged Prospects: ‘Watts’ on the horizon for copper & lithium
right-arrow Created with Sketch.
ASM Aust Strategic sees Canada join US in possible funding push for Dubbo
right-arrow Created with Sketch.
RDN Raiden's key target areas found drill ready in cultural heritage survey
right-arrow Created with Sketch.
RCE Recce wins safety board approval to dose 4g in R327 UTI infusion trial
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.